QIAGEN N.V. Financing Receivable, Credit Loss, Expense (Reversal)
QIAGEN N.V. (QGEN) reported Financing Receivable, Credit Loss, Expense (Reversal) of $0 for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-20.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ProvisionForLoanLossesExpensed · last filed 2026-03-20
| Period end | Financing Receivable, Credit Loss, Expense (Reversal) 12 month |
|---|---|
| 2025-12-31 | $0.00 20-F · filed 2026-03-20 |
| 2024-12-31 | -$5.00K 20-F · filed 2026-03-20 |
| 2023-12-31 | $5.00K 20-F · filed 2026-03-20 |
| 2022-12-31 | $5.57M 20-F · filed 2025-03-31 |
| 2021-12-31 | $2.15M 20-F · filed 2024-03-11 |
| 2020-12-31 | $1.32M 20-F · filed 2023-03-13 |